Sign in

CIK 0001735438

  • Non-accelerated filer
  • Smaller reporting company

MeiraGTx Holdings plc

Sign in to watch
Ticker
MGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
981448305
Phone
+1 646-860-7985
Business address
655 THIRD AVENUE, SUITE 1115, NEW YORK, NY, 10017
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy CHIEF MEDICAL OFFICER bought 5,000 shares at an average $7.90 ($39,500)
  8. 4 Open-market buy GENERAL COUNSEL AND SECRETARY bought 1,000 shares at $7.94 ($7,940)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Shares withheld for taxes President and CEO gave up 51,554 shares (to pay taxes)
  12. 4 Shares withheld for taxes CFO & COO gave up 39,657 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Development Officer gave up 37,600 shares (to pay taxes)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 5 Insider Annual Insider Trading Report
  17. 5 Insider Annual Insider Trading Report
  18. 4 Open-market sale President and CEO sold 30,000 shares at an average $19.92 ($597,472)
  19. 4 Open-market sale CFO & COO sold 22,000 shares at an average $20.99 ($461,777)
  20. 4 Open-market sale President and CEO sold 30,000 shares at an average $17.36 ($520,687)

Page 8 of 13 · 260 filings